Sun, Nov 23, 2014, 12:22 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Oncolytics Biotech Inc. Message Board

  • nutr41 nutr41 Mar 4, 2013 11:30 PM Flag

    UK Publication

    Thx to botinsel on V2 board:
    htt..............ww....thestar.co.uk/news/health/healthy-living-1-5465469

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • So why does this thing continue to FALL??? It's like there's no bottom

    • Published on Monday 4 March 2013 10:04
      12 years ago John was told he had terminal cancer, but he’s still Living the Dream
      Nothing could have prepared John Price for the heartbreaking prospect of not living to see his two children grow up - the bleak future he faced when doctors delivered the devastating news that he was suffering from terminal cancer.
      But 12 years on, John, aged 59, is still living life to the full and looking forward to building precious family memories that once seemed an impossible dream.
      His survival is thanks to a ground-breaking drugs trial at Sheffield’s Weston Park Hospital - and after 10 years of being clear from cancer. John is hoping to fund further pioneering research by raising a record amount of money for the hospital, while at the same time raising awareness of prostate cancer.
      John, from Sandygate, holds an annual golf day in aid of Weston Park, and hopes to reach a total of £120,000 with this year’s event, which will be followed by a Blues Brothers night the following evening, involving family, friends, businesses and sponsors.
      “Put very simply, the research study at Weston Park Hospital saved my life and meant that I was able to see my children grow up,” he said.
      “I will be forever grateful to Weston Park Hospital and will gladly continue to support and fund the groundbreaking research and treatment that happens there every single day. I would urge anyone, if worried, to visit the doctors and get checked out.”
      John was initially diagnosed with kidney cancer in 1998. Although he made a good recovery, in 2001 he was given the devastating news that he had developed secondary cancers and this time the diagnosis was terminal.
      At the same time, Weston Park was conducting a research study into the use of a new form of cancer treatment called ‘magic bullets’.
      John was able to participate in the trial, which resulted in the four tumours that had developed significantly decreasing in size and eventually disappearing entirely.
      The experiment involved using the drug Reolysin, which contains particles of a harmless virus which normally causes stomach upsets.
      The common virus is injected into patients and boosts their immune systems, blasting away tumours. Used alongside radiotherapy, it creates a potent combination that makes the disease more treatable.
      Clinical oncologist Professor Barry Hancock, who treated John, said: “Eleven years ago John came to the clinical trials centre when his kidney cancer had started to spread.
      “He enthusiastically agreed to take part in a Medical Research Council international clinical trial involving new biological therapies and in which Sheffield was one of the lead investigators. It was wonderful to see the cancer clear completely on this treatment and we are delighted that John remains in complete remission to this day.

      Sentiment: Strong Buy

    • Doesn't get better than this! There are other stories like this. We are talking "cure" for some? Many?

      "It was wonderful to see the cancer clear completely on this treatment (REOLYSIN) and we are delighted that John remains in complete remission to this day.”

      Sentiment: Strong Buy

    • Primary AND mets. Inspiring story which certain posters (cough, cough) should read.

 
ONCY
0.6943+0.0343(+5.20%)Nov 21 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.